ECH (iShares MSCI Chile ETF) Stock Analysis - News

iShares MSCI Chile ETF (ECH) is a publicly traded the market company. As of May 21, 2026, ECH trades at $40.13 with a market cap of $0 and a P/E ratio of 0.00. ECH moved +3.05% today. Year to date, ECH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces ECH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in ECH news today?

iShares MSCI Chile ETF Could Benefit from $21B Emerging Market ETF Inflows: Latin America equity ETFs surged in January as emerging market equity ETFs attracted $21 billion, tripling the previous monthly record. Strong rallies—including South Korea’s almost 30% gain—have driven investor demand for country-specific ETFs, potentially boosting flows into the Chile-focused iShares MSCI Chile ETF.

ECH Key Metrics

Key financial metrics for ECH
MetricValue
Price$40.13
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume164.27K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ECH News

ECH Analyst Consensus

ECH analyst coverage data. Average price target: $0.00.

Common questions about ECH

What changed in ECH news today?
iShares MSCI Chile ETF Could Benefit from $21B Emerging Market ETF Inflows: Latin America equity ETFs surged in January as emerging market equity ETFs attracted $21 billion, tripling the previous monthly record. Strong rallies—including South Korea’s almost 30% gain—have driven investor demand for country-specific ETFs, potentially boosting flows into the Chile-focused iShares MSCI Chile ETF.
Does Rallies summarize ECH news?
Yes. Rallies summarizes ECH news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is ECH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ECH. It does not provide personalized investment advice.
ECH

ECH